How Does Accelerated Approval Impact Clinical Trials?
Accelerated approval can significantly shorten the timeline for clinical trials. Researchers can use surrogate endpoints, such as biological markers, instead of waiting for long-term clinical outcomes. This allows for faster data collection and analysis. However, post-marketing studies are often required to confirm the anticipated clinical benefits.
